526139 TRABI

Transgene Biotek Share Price

₹7.49 +0.16 (2.18%)

21 Dec, 2024 18:23

SIP TrendupStart SIP in TRABI

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 11.29%
  • Over 3 Month -4.22%
  • Over 6 Month -16.41%
  • Over 1 Year -32.52%
SIP Lightning

Smart Investing Starts Here Start SIP with Transgene Biotek for Steady Growth!

Invest Now

Transgene Biotek Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Transgene Biotek Financials

Transgene Biotek Technicals

EMA & SMA

Current Price
₹7.49
+ 0.16 (2.18%)
pointer
  • stock-down_img
  • Bullish Moving Average 11
  • stock-up_img
  • Bearish Moving Average 5
  • 20 Day
  • ₹7.21
  • 50 Day
  • ₹7.24
  • 100 Day
  • ₹7.54
  • 200 Day
  • ₹7.67

Resistance and Support

7.52 Pivot Speed
  • R3 8.61
  • R2 8.26
  • R1 7.87
  • S1 7.13
  • S2 6.78
  • S3 6.39

What's your outlook on Transgene Biotek?

You can only vote for once

Transgene Biotek Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results & A.G.M.
2024-08-10 Quarterly Results
2024-05-30 Audited Results
2024-02-14 Quarterly Results
2023-11-14 Quarterly Results & Others

Transgene Biotek F&O

Transgene Biotek Shareholding Pattern

No data available.

About Transgene Biotek

  • NSE Symbol
  • TRABI
  • BSE Symbol
  • 526139
  • ISIN
  • INE773D01018

Similar Stocks to Transgene Biotek

Transgene Biotek FAQs

Transgene Biotek share price is ₹7 As on 21 December, 2024 | 18:09

The Market Cap of Transgene Biotek is ₹56.8 Cr As on 21 December, 2024 | 18:09

The P/E ratio of Transgene Biotek is -213.8 As on 21 December, 2024 | 18:09

The PB ratio of Transgene Biotek is 5.3 As on 21 December, 2024 | 18:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23